Andrew Scott
Geen lopende functies
Profiel
Andrew Scott worked as Vice President of Business Development at Fortress Biotech, Inc. and Vice President of Corporate Development at Oncolix, Inc. He obtained an undergraduate degree from Pace University.
Eerdere bekende functies van Andrew Scott
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCOLIX, INC. | Corporate Officer/Principal | - |
| FORTRESS BIOTECH, INC. | Corporate Officer/Principal | - |
Opleiding van Andrew Scott
| Pace University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| FORTRESS BIOTECH, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Oncolix, Inc.
 Oncolix, Inc. Pharmaceuticals: MajorHealth Technology Oncolix, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of medical therapies for the treatment of various cancers including ovarian, breast, uterine, and prostate. Its brand Prolanta is a drug designed to block the effect of human prolactin in cancers, either as a stand-alone therapy or in combination with other drugs, by blocking the effect of human prolactin. The company was founded on June 2013 and is headquartered in Houston, TX. | Health Technology |
